Dr. Sarah Elizabeth Schmitt, MD

Dr. Schmitt practices at MUSC Physicians in Mount Pleasant, South Carolina.

Dr. Schmitt's NPI, 1437214681, was assigned on December 27, 2006. Dr. Schmitt graduated from Washington University School of Medicine in 2003. Dr. Schmitt holds South Carolina license 38778.

Dr. Schmitt's primary practice is MUSC Physicians, at 1208 2 Island Ct, Mount Pleasant, SC 29466 in Charleston County. The practice phone is (803) 286-4666.

Dr. Schmitt's primary practice is MUSC Physicians in Mount Pleasant, South Carolina. Dr. Schmitt is also affiliated with MUSC Health University Medical Center. The medical group on file is MUSC Health. Dmand AI also links Dr. Schmitt to 3 more hospitals, 3 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schmitt practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Schmitt's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Schmitt's licenses on file in 2 states: South Carolina and Pennsylvania.

CMS data shows 357 Medicare services from Dr. Schmitt across 8 procedure codes in 2024, for 295 Medicare patients. Medicare paid $31,244 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 295 Medicare patients who saw Dr. Schmitt in 2024. The largest group is 65 to 74, with 112 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 2.13, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Schmitt's median patient age at 55, with 57% women.

In 2024, Dr. Schmitt wrote 663 Medicare Part D claims for 72 patients. 83% of them were for generic drugs. CMS names the drug for 473 of them, across 14 drugs with 11 or more claims each, at $210,725 in total drug cost. In 2023, CMS named 413 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Schmitt for performance year 2024, reported as part of a group. Dr. Schmitt accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Schmitt as offering telehealth.

CMS Open Payments shows 11 general payments to Dr. Schmitt from 3 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. SK Life Science, Inc. paid the most, $86.

Dr. Schmitt graduated from Washington University School of Medicine in 2003.